Daniel Levy
36Patents
9h-index
64Co-inventors
78Inventor score
Filing activity: Aug 4, 1993 → Aug 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5892112A | Process for preparing synthetic matrix metalloprotease inhibitors | Chemistry; Metallurgy | 52 | Expired |
| US5789385A | Sialyl Lewis.sup.x mimetics containing phenyl backbones | Chemistry; Metallurgy | 47 | Expired |
| US5658880A | Sialic acid/fucose based medicaments | Chemistry; Metallurgy | 44 | Expired |
| US5654282A | Selectin binding glycopeptides | Human Necessities | 40 | Expired |
| US5837689A | Sialyl lewis-x mimetics containing naphthyl backbones | Chemistry; Metallurgy | 39 | Expired |
| US7115741B2 | 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds | Chemistry; Metallurgy | 33 | Expired |
| US6316465A | Ophthalmic uses of PPARgamma agonists and PPARgamma antagonists | Human Necessities | 17 | Expired |
| US5773438A | Synthetic matrix metalloprotease inhibitors and use thereof | Chemistry; Metallurgy | 14 | Expired |
| US10479795B2 | Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors | Chemistry; Metallurgy | 12 | Active |
| US6887880B2 | Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions, and method of use thereof | Human Necessities | 9 | Expired |
| US11130760B2 | Polymorphic form of sepiapterin | Chemistry; Metallurgy | 8 | Active |
| US11072614B2 | Polymorphs of sepiapterin and salts thereof | Human Necessities | 8 | Active |
| US5508387A | Selectin binding glycopeptides | Human Necessities | 6 | Expired |
| US10975088B2 | Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors | Chemistry; Metallurgy | 5 | Active |
| US11752154B2 | Pharmaceutical compositions comprising sepiapterin and uses thereof | Human Necessities | 5 | Active |
| US11773097B2 | Polymorphs of sepiapterin and salts thereof | Human Necessities | 5 | Active |
| US10738057B2 | Tertiary alcohols as PI3K-γ inhibitors | Chemistry; Metallurgy | 4 | Active |
| US11780840B2 | Tricyclic urea compounds as JAK2 V617F inhibitors | Chemistry; Metallurgy | 3 | Active |
| US11046658B2 | Aminopyrazine derivatives as PI3K-γ inhibitors | Chemistry; Metallurgy | 3 | Active |
| US11225486B2 | Tertiary alcohols as PI3K-γ inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11186580B2 | Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor | Chemistry; Metallurgy | 2 | Active |
| US10975111B2 | Cardiopathy-reducing phosphodiester lipids | Human Necessities | 2 | Active |
| US9951061B2 | CaMKII inhibitors and uses thereof | Human Necessities | 1 | Active |
| US11661422B2 | Tricyclic urea compounds as JAK2 V617F inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11926630B2 | Tertiary alcohols as PI3K-γ inhibitors | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.